Stock OFIX ORTHOFIX MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Orthofix Medical Inc.

Equities

OFIX

US68752M1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
13.09 USD +0.77% Intraday chart for Orthofix Medical Inc. +0.08% -2.89%
Apr. 16 Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer CI
Apr. 12 Orthofix Medical Inc. Announces Board Resignation CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set
MT
Orthofix Medical Inc. Provides Revenue Guidance for the First Quarter, Second Quarter and Third Quarter of 2024
CI
Orthofix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q4 Revenue $200.4M, vs. Street Est of $195.6M
MT
Orthofix Medical Guides For 2024 Sales of $785-$795 Million, vs CIQ Analyst Consensus of $799 Million
MT
Orthofix Medical Inc. Provides Earnings Guidance for the Year 2024
CI
Orthofix Medical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Orthofixan Signs Deal to Distribute BoneMRI Imaging Software in US
MT
Orthofix Announces Commercial Partnership with MRIguidance
CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Posts Q4 Revenue $200.3M
MT
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
CI
Orthofix Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Posts Q3 EPS $0.07
MT
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q3 Revenue $184M, vs. Street Est of $185.8M
MT
Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023
CI
Orthofix Medical Inc. Announces Full Commercial Launch of the Waveform L Interbody System for Lateral Lumbar Fusion Procedures
CI
Orthofix Medical Inc. Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for Use in Spine and Orthopedic Procedures
CI
Orthofix Medical Says External Fixation System for Fracture Treatments Fully Launched Commercially in US
MT
Orthofix Medical Inc. Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures
CI
Orthofix Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OFIX Stock
  4. News Orthofix Medical Inc.
  5. Highlights